GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 32165494
Publication Date: 2020/03/12

The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity.


We previously reported that overexpression of cytochrome P450 family 24 subfamily A member 1 (CYP24A1) increases lung cancer cell proliferation by activating RAS signaling and that CYP24A1 knockdown inhibits tumor growth. However, the mechanism of CYP24A1-mediated cancer cell proliferation remains unclear. Here, we conducted cell synchronization and biochemical experiments in lung adenocarcinoma cells, revealing a link between CYP24A1 and anaphase-promoting complex (APC), a key cell cycle regulator. We demonstrate that CYP24A1 expression is cell cycle-dependent; it was higher in the G-M phase and diminished upon G entry. CYP24A1 has a functional destruction box (D-box) motif that allows binding with two APC adaptors, CDC20-homologue 1 (CDH1) and cell division cycle 20 (CDC20). Unlike other APC substrates, however, CYP24A1 acted as a pseudo-substrate, inhibiting CDH1 activity and promoting mitotic progression. Conversely, overexpression of a CYP24A1 D-box mutant compromised CDH1 binding, allowing CDH1 hyperactivation, thereby hastening degradation of its substrates cyclin B1 and CDC20, and accumulation of the CDC20 substrate p21, prolonging mitotic exit. These activities also occurred with a CYP24A1 isoform 2 lacking the catalytic cysteine (Cys-462), suggesting that CYP24A1's oncogenic potential is independent of its catalytic activity. CYP24A1 degradation reduced clonogenic survival of mutant -driven lung cancer cells, and calcitriol treatment increased CYP24A1 levels and tumor burden in mice. These results disclose a catalytic activity-independent growth-promoting role of CYP24A1 in mutant -driven lung cancer. This suggests that CYP24A1 could be therapeutically targeted in lung cancers in which its expression is high.
Authors: Huang Wei , Ray Paramita , Ji Wenbin , Wang Zhuwen , Nancarrow Derek , Chen Guoan , Galbán Stefanie , Lawrence Theodore S , Beer David G , Rehemtulla Alnawaz , Ramnath Nithya , Ray Dipankar ,

Reference:

  1. ncbi.nlm.nih.gov. [Last access 2020/03/12].

Related products :

Catalog number Product name Quantity
YSRTAHP624Z Cytochrome p450 Control Rabbit Serum (neg for Human Cytochrome p450's by WB_No Inhibit catalytic activity), azide_free; WB_Inhibition assays 0.1 ml.
K3011-1 P450 Demethylation Activity kit (2 plate) The Cytochrome P450 Activity kit is designed to measure the enzymatic activity of demethylation processes carried out by Cytochrome P450. The unique feature o 192 rxns
25-510 ZMIZ1 increases ligand-dependent transcriptional activity of AR and promotes AR sumoylation. The stimulation of AR activity is dependent upon sumoylation. 0.05 mg
DL-CYP24A1-Hu Human Cytochrome P450 24A1 (CYP24A1) ELISA Kit 96T
EIAAB08868 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial,24-OHase,Cyp24,Cyp24a1,Cytochrome P450 24A1,Cytochrome P450-CC24,Rat,Rattus norvegicus,Vitamin D(3) 24-hydroxylase